getting vaccinated after you’ve recovered from the Covid-19 will likely offer you much better protection against the Omicron variant than relying solely on whatever “natural immunity” you ...

Researchers have outlined the pervasive ability of the Omicron variant of SARS-CoV-2 to re-infect ... of vaccinations and immunity through infection, known as hybrid immunity, were even better ...

“Herd immunity is an elusive concept and doesn ... Those mutants – such as omicron – can become better at evading the protection people have from vaccines or an earlier infection.

Brazilian scientists conducted the first research project to evaluate the immunity induced in an actual group of vaccinated ...

A major bivalent COVID-19 vaccine induces production of neutralizing antibodies against the coronavirus that circulated at the start of the pandemic as well as subvariants of omicron, albeit less ...

Omicron has been described as ... This is called hybrid immunity, and other research has similarly found it provides better ...

some experts fear it will be better at evading our immune responses, including those made stronger with vaccines. The number of genetic differences between this variant and Omicron is roughly the ...

"It’s just some are slightly better at ... "We have waning immunity now in the people who got boosted half a year or more ago," Montefiori said. The FDA estimates that omicron-specific boosters ...

The new "FLiRT" COVID-19 variants, including the now dominant KP.2 strain, are circulating in the US. Experts discuss ...

Will Omicron lead us to herd immunity ... In times like these, it is essential to boost your immunity and nothing's better than nature's way to do it. Here are some unique tea blends that can ...

Opinions expressed by Forbes Contributors are their own. I am the CIO of KraneShares, a China-focused ETF provider. Asian markets were mixed overnight though Mainland China was flat as global ...

This was the first research project conducted to evaluate the immunity induced by the Pfizer-BioNTech bivalent vaccine (COMIRNATY Original/omicron BA.4-5) in a group of Brazilian subjects.